US 2017/0204140 A1Published application

Antagonistic peptides

OwnerCenk Suphiogluinventor

Life of this patent

Estimating the term…

Abstract

The present invention relates to a compositions and methods for treating and/or preventing neurologic disorders such as Alzheimer's disease and disorders associated with an increase of the Th2 immune response such as allergic inflammation.

Claims43

Dependent claims

An isolated polypeptide that binds specifically to BACE1 and/or IL-4Rα, wherein the polypeptide comprises the amino acid sequence FHESWPTFLSPS (SEQ ID NO:

1) or a biologically active derivative thereof.

Dependencies are inferred from the claim text.

Facts

Application: 15/328,309Filed 23 Jul 2015
Priority: AU 201490284423 Jul 2014
Published: 20 Jul 2017
Term ends: Not estimatedThe source records don’t support an estimate.

Classification11 codes

C07K 7/08
Linear peptides containing only normal peptide links: having 12 to 20 amino acids
A61K 38/10
Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof: peptides having 12 to 20 amino acids
A61P 25/28
Drugs for disorders of the nervous system: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents,…
A61P 37/08
Drugs for immunological or allergic disorders: antiallergic agents

Family

No related US applications are recorded in the indexed filing history.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results